Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00780273 · ClinicalTrials.gov registry record · Phase 4
Success Rate of Immediately Loaded Implants With Platform Switched Design Placed in Anterior Part of Mandible and Restored With Fixed Prostheses
A Phase 4 study of Edentulism, sponsored by Dentsply International.
- Completed
- Registry status
- Phase 4
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT00780273: Completed Phase 4 study of Edentulism, sponsored by Dentsply International.
NCT00780273 is a Phase 4 study of Edentulism that has completed, run by Dentsply International. The registered enrollment target is 19 participants, below the 190-participant average among 4 other Edentulism trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00780273, a Phase 4 study of Edentulism, has completed, sponsored by Dentsply International.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
Change in crestal bone level implants at 5% significance level.
Primary Outcome
Incidence of greater than 2 mm crestal bone (mesial or distal) loss. Reported in the percentage of analyzed implants.
Conditions Studied
Interventions
- DEVICE Ankylos Implants
- DEVICE Biomet 3i Prevail Implants
Study Locations (1)
New York
- University of Rochester, Eastman Dept of Dentistry - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2008-09 |
| Est. Completion | 2012-04 |
| Phase | Phase 4 |
What the finished NCT00780273 record still lists
NCT00780273 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 190-participant average among 4 other Edentulism trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Edentulism appearing as the primary indexed condition, and to 2 interventions - of which Ankylos Implants is the first listed.
NCT00780273 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00780273 about?
NCT00780273 is a clinical study titled "Success Rate of Immediately Loaded Implants With Platform Switched Design Placed in Anterior Part of Mandible and Restored With Fixed Prostheses". Change in crestal bone level implants at 5% significance level.
What is the current status of trial NCT00780273?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2008-09. Estimated completion is 2012-04.
What conditions does trial NCT00780273 study?
This clinical trial studies the following conditions: Edentulism.
What interventions are being tested in trial NCT00780273?
The interventions under investigation include: Ankylos Implants (DEVICE), Biomet 3i Prevail Implants (DEVICE).
Who is sponsoring clinical trial NCT00780273?
This trial is sponsored by Dentsply International, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00780273 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Edentulism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dental Implant Healing With TNF-Alpha Inhibitors
RECRUITING · NA
-
Platelet-Rich Fibrinogen in Extraction Socket Healing of the Aged
RECRUITING · NA
-
5-Years PMCF Study of Ceramic Dental Implants One-piece Versus Two-piece.
RECRUITING
-
Study to Evaluate an Implant With a Sloped Top in Patients With a Sloped Jaw Bone
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia